Marcus Deans

Marcus Deans has acquired extensive practical and academic experience of Strategic Marketing and Market Access over an 18 year career. Marcus focusses on the launch and the development of Market Access strategies for Medicinal Products and Medical Devices (including in vitro diagnostics), within Deallus. Marcus’ core objective is to ensure product developers optimise the manner in which they bring their innovative technologies to market through the design and implementation of strong Market Access and Pricing strategies in combination with Deallus’ heritage in ‘Competitor Strategy’. Thus providing a holistic and integrated approach to product launch Marcus’s previous experience has focused on launching drugs & medical devices, through an in depth understanding of both regulatory & reimbursement dynamics in the EU & US. Prior to joining Deallus, Marcus was the Global Vice President and European Vice President at Voisin Consulting & GfK Bridgehead respectively. Both are leading specialist consultancies in Regulatory and Market Access & Pricing strategy. Before moving into consulting, Marcus held a number of industry positions, including European Pricing & Market Access Director at Takeda, Head of European CNS (Strategic Marketing) at Eisai and Global Brand Director at Novartis where he managed a number of brands through both launch and loss of exclusivity (LOE). Marcus is based in the Deallus HQ –? London, UK.